SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-20-022143
Filing Date
2020-02-18
Accepted
2020-02-14 21:34:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a20-8182_1sc13ga.htm SC 13G/A 52291
  Complete submission text file 0001104659-20-022143.txt   53579
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Subject) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87209 | Film No.: 20623094
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O STEMLINE THERAPEUTICS, INC. 750 LEXINGTON AVENUE, 6TH FLOOR NEW YORK NY 10022
Business Address
Bergstein Ivan (Filed by) CIK: 0001554767 (see all company filings)

Type: SC 13G/A